81816-60-6 Usage
General Description
6-methoxychroman-4-amine is a chemical compound with a molecular formula of C10H13NO2. It is also known as 4-amino-6-methoxychromane and is a derivative of chromane. It is a white to off-white solid and is soluble in organic solvents. 6-methoxychroman-4-amine has potential applications in pharmaceuticals and organic synthesis. It may be used as a building block for the synthesis of various bioactive compounds and may also have medicinal properties. Additionally, it is used as an intermediate in the production of other chemicals and as a research chemical in scientific studies. Further research and testing on its properties and potential uses may reveal more about the capabilities and applications of 6-methoxychroman-4-amine.
Check Digit Verification of cas no
The CAS Registry Mumber 81816-60-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,8,1 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 81816-60:
(7*8)+(6*1)+(5*8)+(4*1)+(3*6)+(2*6)+(1*0)=136
136 % 10 = 6
So 81816-60-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2/c1-12-7-2-3-10-8(6-7)9(11)4-5-13-10/h2-3,6,9H,4-5,11H2,1H3
81816-60-6Relevant articles and documents
8-SUBSTITUTED 2-(BENZIMIDAZOLYL)PURINE DERIVATIVES FOR IMMUNOSUPPRESSION
-
Page/Page column 9, (2008/06/13)
The present invention provides novel purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula I:
Phenoxyalkylamines in Semi-rigid Conformation: Synthesis & Pharmacological Activity of N1-(4'-Chromanyl)-N4-arylpiperazines & N1-(2'-Chromanylmethyl)-N4-arylpiperazines
Pratap, Ram,Gupta, R. C.,Anand, Nitya
, p. 1063 - 1067 (2007/10/02)
Synthesis and pharmacological activity of N1-(4'-chromanyl)-N4-arylpiperazines and N1-(chromanylmethyl)-N4-arylpiperazines, cyclic congeners of N1-aryloxyalkyl-N4-arylpiperazines, are reported.None of the compounds of this series shows any significant pharmacological activity.